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Abstract
Background: Natural killer (NK) cells in the cow have been elusive due to the lack of specific NK
cell markers, and various criteria including a CD3-/CD2+ phenotype have been used to identify such
cells. The recent characterization of the NK-specific NKp46 receptor has allowed a more precise
definition of bovine NK cells. NK cells are known as a heterogeneous cell group, and we here
report the first functional study of bovine NK cell subsets, based on the expression of CD2.
Results: Bovine CD2- NK cells, a minor subset in blood, proliferated more rapidly in the presence
of IL-2, dominating the cultures after a few days. Grown separately with IL-2, CD2- and CD2+ NK
cell subsets did not change CD2 expression for at least two weeks. In blood, CD2- NK cells showed
a higher expression of CD44 and CD25, consistent with a high activation status. A higher
proportion of CD2- NK cells had intracellular interferon-gamma in the cytoplasm in response to
IL-2 and IL-12 stimulation, and the CD2- subset secreted more interferon-gamma when cultured
separately. Cytotoxic capacity was similar in both subsets, and both carried transcripts for the NK
cell receptors KIR, CD16, CD94 and KLRJ. Ligation by one out of two tested anti-CD2 monoclonal
antibodies could trigger interferon-gamma production from NK cells, but neither of them could
alter cytotoxicity.
Conclusion: These results provide evidence that bovine CD2- as well as CD2+ cells of the NKp46+
phenotype are fully functional NK cells, the CD2- subset showing signs of being more activated in
the circulation.
Background
Natural killer cells were initially defined as a heterogene-
ous population of large granular lymphocytes that were
able to spontaneously kill target cells. Human natural
killer cells were later phenotypically defined as CD3-/
CD56+ lymphocytes [1], and can be divided into distinct
functional subsets, the CD56bright being mainly cytokine
producers and CD56dim being more effective killers [2].
Mice and rats do not express CD56 on haematopoietic
cells; thus NK cells in these species are instead defined as
non-T lymphocytes bearing NKR-P1 molecules [3],
although the use of NKp46 as the standard NK cell identi-
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fier in the rat has been suggested [4]. There is less evidence
for a clear functional division of NK cells in rodents [5].
Criteria for the definition of NK cells have not been clari-
fied in most farm animal species [6]. In the cow, NK-like
cells have been described as CD3-/CD2+ lymphocytes [7-
10], and NK-like cells have been isolated on the basis of
markers not commonly expressed by NK cells [11].
Recently, the characterization of bovine NKp46 (CD335)
enabled a more precise identification of bovine NK cells
[12]. The NKp46 receptor has been proposed as the most
accurate marker for human NK cells [13], as it is highly
NK-restricted and uniformly expressed by cultured as well
as resting NK cells [14-16].
The CD2 molecule is known as an adhesion molecule as
well as a receptor for activation on both NK cells and T-
cells, reviewed in [17]. In the cow, CD2 is frequently used
as a cell marker in cellular immunology, and several anti-
bovine CD2 monoclonal antibodies (mAbs) have been
described [18,19]. The functional role of CD2 in bovine
NK cells has not been previously studied, but NKp46+ cells
in cattle peripheral blood can be divided into distinct
CD2+ and CD2- phenotypes, the latter typically compris-
ing around 20% of the cells [12]. Similar proportions
have been reported in human blood [20,21], but only a
few studies have been published that functionally
describe CD2- NK cells from blood in healthy humans
[22-24]. There does not seem to be a strong difference in
expression of CD2 between the human CD56bright and
CD56dim NK cell subsets [2]. In the mouse, CD2- cells has
been associated with immature cell stages [5], but block-
ing and knock-out experiments have shown that CD2 is
not necessary for well-developed NK cell function [25,26].
Accordingly, CD2 has been classified as a co-receptor [27],
although the use of this term has been questioned, since
apparently no known activating NK cell receptor stand out
as dominating, unlike in T-cells [16].
The scope of the present study was to investigate bovine
NK cell subsets, defined by CD2 expression. Our results
show that both subsets are fully capable of NK cell activ-
ity, and blocking experiments confirm a redundancy of
CD2 for NK cell function. Furthermore, the CD2- subset is
more activated in circulation and show a stronger prolif-
erative and interferon-gamma (IFN-γ) producing capacity.
Results
CD2 expression in peripheral blood and IL-2 activated NK 
cells
Expression of CD2 was analyzed on NK cells from fresh
peripheral cattle blood, and on isolated NK cells followed
for eleven days in the presence of recombinant bovine
interleukin-2 (rbIL-2) (Fig. 1A). In peripheral blood,
NKp46+ cells were divided into a major CD2 expressing
subset and a minor CD2 non-expressing subset, the latter
CD2 distribution on bovine NK cells in peripheral blood and  during cell culture Figure 1
CD2 distribution on bovine NK cells in peripheral 
blood and during cell culture. (A) CD2 expression by 
PBMCs from healthy cattle, and in NKp46-selected cells cul-
tured for the indicated time in the presence of 100U/ml rbIL-
2. Results were obtained by two-colour flow cytometry, gat-
ing for viable lymphocytes. Data shown are from one animal 
representative of 19. (B) Monitoring of cell divisions of CD2- 
and CD2+ NK cell populations during three and six days of 
rbIL-2 (100U/ml) stimulation. NKp46-selected cells were 
labelled with CFSE the day after isolation and CFSE intensity 
(filled histograms) measured in flow cytometry on the indi-
cated days, gating for CD2- or CD2+ viable cells. Solid line 
open histograms show non-dividing NK cells, cultured in the 
presence of 1U/ml rbIL-2, while broken line open histograms 
show unlabeled stimulated NK cells. Data shown are from 
one animal representative of five. (C) Stability of CD2 
expression in NK cell subsets cultured separately. NK cells 
separated with immunomagnetic beads for absence or pres-
ence of CD2 were cultured separately for eleven days in the 
presence of IL-2, monitoring CD2 expression at three differ-
ent time points (filled histograms). Day 1 corresponds to the 
day of separation, 24 h after primary NK cell isolation. Open 
histograms show secondary mAb controls. Data shown are 
from one animal representative of eight.
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typically comprising between 15 to 30% of the NK cells.
Following rbIL-2 activation, a moderate increase in the
CD2 intensity was observed for both subsets, thus the ini-
tially negative population will in the following be named
CD2-/low when rbIL-2 activated. The proportion of CD2-/
low cells increased during eleven days of culture and com-
prised 60–90% of the cells at the end of the period; this
pattern was maintained for at least three weeks (not
shown).
To elucidate the proliferation of these subsets, NK cells
were stained with the cell division marker carboxyfluores-
cein diacetate succinimidyl ester (CFSE) on the day after
isolation, and cultured in the presence of rbIL-2, using
quiescent NK cells as controls [28]. Three days later, the
CD2-/low subset had decreased more in CFSE intensity
than the CD2+ subset, indicating that the former subset
had proliferated more vigorously (Fig. 1B). However, after
six days in culture, CFSE intensity in the two subsets were
almost similar, indicating that CD2+ NK cells entered pro-
liferation at a later stage than the CD2-/low cells.
To further clarify if the CD2+ and CD2-/low cells were dis-
tinct subsets, NK cells were divided by immunomagnetic
beads into CD2 expressing and non-expressing subsets
the day after NK cell isolation, and cultured in rbIL-2 con-
taining medium for ten consecutive days. Throughout this
period, no major change of the expression of CD2 was
observed (Fig. 1C). The tendency of a low CD2 expression
on part of the CD2- subset, as seen with non-separated
cells, was not clear in these separated cell cultures. A fre-
quent observation made was that the CD2-depleted NK
cells entered an exponential growth phase at an earlier
stage than the CD2 selected cells, in accordance with the
CFSE labelling results.
Phenotype of CD2-defined subsets of NK cells in 
peripheral blood and following IL-2 activation
The expression of selected surface markers in relation to
CD2 expression on NK-cells was analyzed in freshly
drawn peripheral blood, and following culture of isolated
NK cells for 5 and 12 days. In peripheral blood, the great-
est difference was seen in expression of CD44, which was
brightly expressed by all CD2- NK cells, and present but
more spread out at lower intensities on CD2+ NK cells
(Fig. 2A). Most NK cells were weakly CD11c positive, but
for this marker the CD2- subset labelled less intensely than
the CD2+ subset. Similarly, CD45RO was less intensely
expressed by the CD2- subset. CD11b was expressed by a
minor part of NK cells, similarly in both subsets. A minor
part of NK cells, but proportionally more within the CD2-
subset, expressed CD25 (IL-2Rα).
Following isolation and culture of bovine NK cells for five
days in the presence of rbIL-2, differences between the
subsets became less clear (Fig. 2B). At this time CD44 and
CD25 were clearly upregulated and expressed by almost
all NK cells, CD11c and CD45RO were slightly upregu-
lated while CD11b remained unchanged. CD44 remained
clearly brighter on the CD2-/low subset and CD11c slightly
brighter on the CD2+ subset.
Following 12 days in rbIL-2 culture, a further upregula-
tion in both subsets was seen for CD44 (intensely bright),
CD45RO and CD25, while CD11c had decreased, and
Expression of activation markers by CD2+ and CD2- subsets  of bovine NK cells Figure 2
Expression of activation markers by CD2+ and CD2- 
subsets of bovine NK cells. Scatter plots show NKp46 
expressing lymphocytes, with CD2 in the x-axis and the indi-
cated marker in the y-axis. PBMCs were analyzed in periph-
eral blood (A), and isolated NKp46+ cells of the same sample 
was cultured in the presence of rbIL-2 and analyzed again 
after 5 (B) and 12 (C) days. Fluorescence settings in the flow 
cytometer were kept unchanged and verified using secondary 
controls (not shown). Mean fluorescence intensity (MFI) of 
the y-axis for each subset is shown for markers showing a 
continous distribution (i), while quadrant percentages are 
shown for one marker with a biphasic distribution (ii). Data 
shown are from one animal representative of eight.
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CD11b remained unchanged (Fig. 2C). At this time, dif-
ferences between the CD2-/low and CD2+ subsets were not
readily distinguishable. After three weeks, as primary NK
cell cultures started to show reduced viability, a similar
phenotype pattern was seen, although CD44 and
CD45RO expression was even further increased in all NK
cells (not shown).
Evaluation of mRNA expression of NK receptor genes in 
CD2- and CD2+ NK cell subsets
mRNA was extracted from NK cell subsets selected as
described above and cultured for one week in the presence
of rbIL-2. Standardized amounts of cDNA synthesized
from these transcripts were analyzed for gene expression
using RT-PCR. Analysis at 25 cycles showed that the two
NK cell subsets expressed the NK receptor genes NKp46
(CD335), KIR, FcγRIIIA (CD16), KLRD1 (CD94) (Fig. 3A)
[29,30]. No difference between the subsets measured as
intensity of bands in agarose gel was detected. The KLRJ
gene was considerably less expressed than the other recep-
tors, and only appeared following 30 cycles (Fig. 3B).
These results demonstrate that common NK cell receptors
are expressed by both the CD2-/low and CD2+ subsets, con-
firming the NK nature of these cells.
IFN-γ production by CD2- and CD2+ NK cell subsets in 
peripheral blood and culture
To assess the capacity for IFN-γ production by peripheral
blood NK cells, heparinized whole blood was cultured
overnight in the absence or presence of rbIL-2 and rbIL-12
and analyzed in flow cytometry for intracellular IFN-γ in
relation to NKp46 and CD2 surface expression. Non-stim-
ulated cultures contained very few IFN-γ positive cells,
and these numbers were used as baseline levels to calcu-
late net increase in stimulated cultures. From cultures
stimulated by both rbIL-2 and rbIL-12, the CD2-/low NK
cells had a markedly higher proportion of IFN-γ produc-
ing cells than the CD2+ subset (Fig. 4A).
IFN-γ secretion by rbIL-2 activated NK cell subsets was
assessed by separating NK cells into CD2- and CD2+ sub-
sets and cultured for one week as described above. Follow-
ing 24 hrs further incubation in the absence or presence of
rbIL-12, the level of IFN-γ in the supernatant was meas-
ured in an ELISA. In the presence of rbIL-12, the CD2-/low
subset produced from 10 to 300% more IFN-γ than CD2+
cells (Fig. 4B). IFN-γ production in the absence of rbIL-12
was negligible (< 1 ng/ml) by both subsets, and were sub-
tracted as baseline levels in the calculation of these
responses. The expression of CD2 was unchanged during
this period, as shown above.
Cytotoxicity of CD2- and CD2+ NK cell subsets
CD2+ and CD2-/low NK cell subsets, isolated and cultured
separately for about one week in the presence of rbIL-2,
were analyzed for cytotoxicity in a 51Cr release assay, using
two previously described target cell lines [12]. The bovine
MDBK cell line was killed moderately more efficiently by
the CD2-/low subset compared with the CD2+ subset by
three out of four animals tested (Fig. 4C). Addition of
anti-NKp46 mAb partly inhibited killing by both subsets
in a similar fashion as previously reported [12] and shown
below (Fig. 5C). In a redirected lysis assay using anti-
NKp46 mAb and the murine FcR-bearing targets P815, the
CD2-/low NK cells was clearly the more cytotoxic subset in
three of six animals tested, almost equal in two, and less
cytotoxic in one (Fig. 4D). In the absence of anti-NKp46
mAb only a very weak killing of P815 was detected, with
no clear subset difference (ranging from 16 to 100 lytic
units [LU]), similar to previous findings [12] and fig. 5D.
Effect of anti-CD2 mAbs on IFN-γ response from NK cells
The ability of CD2 cross-linking to trigger IFN-γ produc-
tion from NK cells was assessed by culturing NK cells for
24 hours in plastic wells pre-coated with anti-CD2 mAbs,
followed by measuring IFN-γ in the supernatants. In wells
coated with one of the two tested anti-CD2-mAbs (mAb
II, MUC2a), an IFN-γ response was measured, while in
wells coated with the other (mAb I, BAQ95A), no
response above background could be measured (Fig. 5A).
This response occurred without rbIL-12, but was potenti-
ated by the presence of this cytokine. The IFN-γ response
by anti-NKp46 mAb was similar to previously obtained
results [31], and was always higher than the anti-CD2
induced response. No IFN-γ above medium controls was
measured with mAbs against CD8, which is present on
most cultured NK cells [12], indicating that the response
seen with MUC2A was CD2-specific.
RT-PCR analysis of NK cell receptor genes in CD2+ and  CD2- NK cell subsets Figure 3
RT-PCR analysis of NK cell receptor genes in CD2+ 
and CD2- NK cell subsets. (A) Separated NK cell subsets 
were cultured for one week in the presence of rbIL-2 and 
analyzed for the indicated NK cell receptors at the mRNA 
transcript level. Results show products following 25 PCR 
cycles, from one animal representative of four. (B) The KLRJ 
gene analyzed as for panel A, following 30 PCR cycles.
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Effect of anti-CD2 mAbs on NK cytotoxicity
Available anti-bovine CD2 mAbs have not been previ-
ously tested for their ability to activate or inhibit NK cell
cytotoxicity. To investigate this, bovine NK cells were pre-
treated with the same two mAbs as mentioned above, and
tested for interference with NK cytotoxicity in 51Cr release
assays. Neither of these mAbs could alter the NK cytotox-
icity against the bovine target cell lines BL-3.1 (Fig. 5B) or
MDBK (Fig. 5C), while anti-NKp46 blocked most of the
killing. A similar result was obtained with the target KN-
31 using NK cells from two animals (not shown). No
induction of redirected lysis was seen with the P815 target
(Fig. 5D), while anti-NKp46 did, like previously reported
[12].
Discussion
The recent characterization of bovine NK cells [12] allows
this important field of innate immunity to be studied in
the cow. Human NK cells can be divided into functional
subsets depending on the level of CD56 expression, but
like in rats and mice, this antigen is probably not present
on NK cells in the cow [11], thus not allowing a direct
comparison with the human subsets. However, CD2
expression divides bovine NK cells into two distinct pop-
ulations [12], and the scope of the present study was to
examine CD2+ and CD2- bovine NK cell subsets for func-
tional properties and status of activation.
Around 20% of NK cells in peripheral blood of cattle did
not express CD2, similar to findings in man [20,21]. Dur-
ing two weeks of primary culture with IL-2, the NK cell
population changed towards a dominance of the CD2-
phenotype. This change tended to be more pronounced in
young animals, but was also present in adults. No inter-
mediate forms were seen at any point, indicating that the
two subsets were discretely preserved. However, under
these unfractioned culturing conditions, the initial CD2-
population appeared to acquire a low density of CD2
receptors. In contrast, no such CD2 acquisition was seen
when CD2-  NK cells were cultured separately. More
detailed studies would be required to explain this phe-
nomenon, but a conceivable hypothesis could be intercel-
lular exchange of receptors during cell culture, as recently
demonstrated [32]. We have consequently chosen to
name these subsets CD2-/low and CD2+ when cultured in
the presence of IL-2. IL-2 is reported to upregulate CD2 on
human NK cells; partly as a minor intensity increase like
observed here, but also as a proportional increase of the
CD2+ population [16,22], unlike our findings. Species dif-
ferences may explain these conflicting proliferation pat-
terns.
Interestingly, the CD2- subset contained the highest rela-
tive numbers of IFN-γ+ NK cells following cytokine stimu-
lation, and IFN-γ secretion to the supernatant was also
stronger following IL-2 stimulation. To our knowledge,
experiments showing IFN-γ responses from correspond-
ing subsets have not been reported in other species. Both
subsets were cytotoxic against conventional target cells,
the CD2-/low most often, but not always, being the most
effective killers. These findings are in agreement with
reports from human NK cells where both subsets were
comparably cytotoxic [22]. We conclude that both subsets
had fully developed natural killer cell functions, the CD2-
/low NK cells being the more effective IFN-γ producers.
To identify appropriate activation markers in bovine NK
cells we analyzed antigens known to be upregulated on
other activated bovine lymphocytes [8,33]. We observed
IL-2-induced upregulation of CD25, CD44 and CD45RO,
Functional properties of CD2- and CD2+ bovine NK cell sub- sets Figure 4
Functional properties of CD2- and CD2+ bovine NK 
cell subsets. (A) Intracellular IFN-γ response in bovine 
heparinized whole blood, stimulated for18 hrs with 200U/ml 
rbIL-2 and 5U/ml rbIL-12. Cells were surface labelled and 
gated for NKp46+ and CD2+ or CD2-, and bars represent net 
per cent cells positive for cytoplasmatic IFN-γ (stimulated 
samples minus unstimulated controls). Each of five tested ani-
mals is shown individually; error bars represent SD of 
repeated assays (n = 1–3). (B) IFN-γ measured in superna-
tants of bovine NK cells separated with respect to CD2 
expression, cultured for around one week in the presence of 
100U/ml rbIL-2 and stimulated for the last 24 hours with 
0.5U/ml rbIL-12. Responses were measured by an ELISA and 
are shown as stimulated samples minus unstimulated con-
trols for individual animals. (C) Cytotoxicity of NK cell sub-
sets obtained likewise, against the bovine kidney cell line 
MDBK, in a 4 hrs 51Cr release assay. Bars represent four 
individual animals and show lytic units (LU) defined as stated 
in Methods. (D) Redirected lysis of FcR-bearing murine P815 
target cells by similar NK cell subsets, in the presence of α-
NKp46 mAb, calculated and presented as in (C).
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in accordance with reports from human NK cells [34-37].
The unchanged CD11b expression and slight but transient
CD11c upregulation in IL-2 culture was also similar to
human NK cells [20].
In peripheral blood NK cells, two of the investigated
markers (CD44 and CD25) were highest on CD2- subset.
Expression of CD25 on NK cells has been associated with
higher proliferative potential [38], providing support for
the increased proliferation of the CD2- subset seen here.
CD2, CD44 as well as the integrins are associated with cell
adhesion, and notably, CD44 has been associated with
binding to high endothelial venules [36]. Hence, the dif-
ferential expression of these as well as CD11c on NK cell
subsets could possibly relate to adhesive and/or migratory
properties, although it has been warned against inferring
in vivo migratory properties based on the expression of
adhesion molecules alone [39].
In contrast to CD44 and CD25, CD45RO was moderately
brighter on the CD2+  subset. Increased expression of
CD45RO has been reported to be a transient phenomena
in human NK cells upon activation [37,40]. , but the role
of this molecule in NK cells remains unclear [41,42]. It is
noteworthy that in parallel to our findings with NK cells,
bovine gamma delta (γδ) T-cells have been reported to
express more CD44 and less CD45 in a CD2- subset,
although it was not stated which isoform of CD45 that
was targeted [33]. Furthermore, human peripheral CD2-/
low T-cells were recently reported to show greater prolifer-
ative capacity as well as CD45RO expression, unlike CD2+
T-cells; these were interpreted to be immature T-cells [43].
They were by definition CD3+, and therefore of a different
lineage, but also in NK cells the lack of CD2 expression
has been linked to immaturity [5,22]. The knowledge of
NK cell development is still limited, but definition criteria
for differentiation stages have recently been suggested
[44]. According to those, the CD2- subset presented here
would qualify as mature NK cells since they show full
cytotoxicity and IFN-γ production. The findings that they
comprise up to 30% of circulating NK cells and express all
NK receptors investigated on the mRNA level would
appear paradoxical if they represent immature stages. Fur-
ther studies would be required to target such aspects.
To complement these studies on NK cell subsets defined
by CD2 expression, we examined the role of the CD2 mol-
ecule itself on bovine NK cells, by employing two bovine
anti-CD2 mAbs in functional NK cell assays. Cross-linking
by one of the mAbs induced a clear IFN-γ response, simi-
lar to studies in human NK cells [45]. Neither of the tested
mAbs blocked cytotoxicity against NK-susceptible targets,
and they did not induce redirected lysis of an FcR-bearing
target. In human NK cells, significant blocking of cytotox-
icity by CD2 mAbs usually does not occur [46], and no
redirected lysis effect was observed [47], although cross-
linking by conjugated mAbs against different epitopes
could trigger cytotoxicity [48-50]. Similar observations
have been done in mice [25]. The human CD2 molecule
has later been shown to contain a continuum of overlap-
ping epitopes, to which different mAbs may bind with
various degrees of functional interference [51]. On this
background, our experiments cannot exclude a CD2 func-
tion in cytotoxicity. Nevertheless, one CD2 mAb that
apparently bound to a reactive epitope, since it could trig-
ger IFN-γ production, did not affect target lysis. Together
with the observation that CD2- NK cells were fully cyto-
toxic and produced IFN-γ, we conclude that, similar to
Effect of anti-CD2 mAbs on bovine NK cell functions Figure 5
Effect of anti-CD2 mAbs on bovine NK cell functions. 
(A) IFN-γ response from NK cells caused by cross-linking of 
CD2. Plastic wells were pre-coated with two different mAbs 
against bovine CD2, along with NKp46-mAb as positive con-
trol and CD8-mAb or medium as negative controls. rbIL-2 
activated NK cells were added and incubated for 24 h in the 
presence or absence of rbIL-12 (0.5 U/ml), and IFN-γ content 
in the supernatants analyzed by an ELISA. Data shown are 
means ± SD of two to four individual animals. (B-C) IL-2 acti-
vated NK cell killing of the bovine target lines BL3.1 and 
MDBK in a 4 h 51Cr-release assay, with addition of the indi-
cated mAbs for blocking. CD2mAb I = BAQ95A, CD2 mAb 
II = MUC2A, CD8 mAb = CACT80C, NKp46 mAb = AKS1. 
(D) As above, using murine Fc-receptor bearing P815 target 
cells to obtain a redirected lysis effect. Data shown in (B-D) 
are from one animal representative of three to five.
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other species, the CD2 molecule is not necessary for
bovine NK cell function.
Bovine NK or NK-like cells have sometimes been defined
as CD3-/CD2+ lymphocytes [7-9]. This may partly have
been founded on reports that bovine PBMCs expressing
CD2 were more cytotoxic than CD2- PBMCs [10]. How-
ever, due to lack of NK-specific markers, those results
could not be adjusted for the relative content of NK cells
within each population. Our studies show that most NK
cells in blood are CD2+. Considering that the majority of
PBMCs do not express CD2, the proportion of CD2- NK
cells would constitute only a small fraction of this popu-
lation, hence providing a likely explanation for the cyto-
toxicity pattern shown by Campos et al. [10].
Furthermore, in a report where CD3-/CD2+ cells were clas-
sified as NK cells, CD3-/CD2-lymphocytes were reported
as a not previously described "null cell" population [8].
Our present and previous studies [12] should provide evi-
dence that these were most likely NK cells. In conclusion,
we find that NK cell definitions based on a CD2+ pheno-
type exclude an important subset of bovine NK cells.
Conclusion
We have demonstrated here that CD2- and CD2+ subsets
of bovine NK cells in peripheral blood have distinct phe-
notypic and functional properties, both subsets fulfilling
criteria for being natural killer cells. The CD2- subset of
NK cells show phenotypical signs of being more activated,
both obtained from blood and during the first days of IL-
2 culture, they are better IFN-γ producers and have higher
proliferative capacity. Both subsets are cytotoxic and carry
mRNA transcripts for a set of common NK cell receptors.
One anti-CD2-mAb could incite an IFN-γ response from
bovine NK cells, but no alteration of cytotoxicity was
found by two tested mAbs. The results presented here
establish NKp46+/CD2- cells as a distinct, activated and
fully functional subset of NK cells in the cow, with a par-
ticular capacity for IFN-γ production.
Methods
Isolation and culture of bovine NK cells and subsets
Clinically healthy Norwegian Red dairy cattle of both
sexes and of different ages above 3 months were used in
this study. Blood samples were collected in tubes with
EDTA as anticoagulant. Peripheral blood mononuclear
cells (PBMC) were obtained by density gradient centrifu-
gation using Lymphoprep (Axis-Shield, Oslo, Norway).
NK cells were isolated and cultured as previously
described [12]. Briefly, PBMC were positively selected
using mAb against NKp46 (CD335) (AKS1;IgG1; Serotec,
Oxford, UK) and immunomagnetic anti-mouse pan IgG
beads (Dynal, Oslo, Norway), and cultured in RPMI
medium supplemented with 60µg/ml penicillin, 100 µg/
ml streptomycin, 1 mM sodium pyruvate, non-essential
amino acids, 50µM 2- mercaptoethanol (all GIBCO, Inv-
itrogen) with 10% FCS and 100 U/ml rbIL-2, produced as
described below. After 24–48 h, beads had undergone
spontaneous detachment and were magnetically
removed. Selection of NK cell subsets was performed after
24 h, by applying the anti-CD2 mAb MUC2A (VMRD,
Pullman, WA, USA) and MACS anti-mouse IgG
MicroBeads and LS columns (both Miltenyi Biotech, Ber-
gish Gladbach, Germany) according to the manufacturer's
instructions. To enhance purity, positive selection was
repeated using a new LS column, and depletion repeated
using an LD column. NK cells or subsets were cultured fur-
ther for the appropriate length of time in rbIL-2-contain-
ing medium.
Flow cytometry
Two- or three-coloured flow cytometric analysis of surface
receptors was performed on whole blood samples or cul-
tured cells, as previously described [12], using the follow-
ing antibodies: CD2 (MUC2A;IgG2a, BAQ95A;IgG1, or
B26A4;IgM), CD11b (BAQ147A;IgM), CD11c
(BAQ153A;IgM), CD25 (CACT108A;IgG2a), CD44
(BAG40A;IgG3), CD45RO (GC44A;IgG3) (all from
VMRD), and NKp46 (AKS1). Subtype-specific secondary
antibodies were conjugated with FITC or PE (Southern
Biotech, Birmingham, AL, USA), or with Alexa Fluor 488
or Alexa Fluor 633 (Molecular Probes, Invitrogen). The
samples were analyzed on a FACS CALIBUR flow cytome-
ter (Becton Dickinson), equipped with Cell-Quest Pro
software. 5 × 104 viable cells as gated in the forward side
scatter plot were analyzed.
CFSE proliferation analysis
For cell proliferation studies, positively selected NK cells
cultured for 20 h in the presence of rbIL-2 were incubated
with 5 µM CFSE in PBS with 0.2% BSA for 10 min fol-
lowed by addition of 5 ml cold RPMI and incubation on
ice for 5 min. The cells were washed three times in RPMI
and cultured in the presence of 100 U/ml rbIL-2 as
described above. To obtain non-proliferating NK cells as
controls, rbIL-2 was added at 1U/ml to washed NK cells;
this amount was obtained by titrating rbIL-2 to an
amount that kept the cells viable, but non-proliferating, as
measured by cell counting and incorporation of 3H
labeled thymidine.
Detection of intracellular and secreted IFN-γ
Bovine PBMCs were analyzed for IFN-γ producing cells as
described previously [52], with modifications. Briefly,
heparinized whole blood was incubated overnight in the
absence or presence of rbIL-2 (200 U/ml), or rbIL-12 (5
U/ml) (kindly provided by Jayne Hope, Institute of Ani-
mal Health, Compton, UK). Twelve hours before harvest-
ing, Brefeldin A (10 µg/ml) (Sigma) was added. PBMC
were isolated by density gradient centrifugation and sur-BMC Immunology 2006, 7:10 http://www.biomedcentral.com/1471-2172/7/10
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face labelling was performed with mAbs against NKp46
(AKS1) and CD2 (MUC2A), and following permeabiliza-
tion and fixation the anti-bovine IFN-γ mAb clone 6.6
(IgG2b) was applied (kindly provided by Gregers
Jungersen, Danish Institute for Food and Veterinary
Research, Copenhagen). 105 cells per sample were ana-
lyzed in a flow cytometer as described above.
For assessment of secreted IFN-γ, NK cell subsets pre-cul-
tured for one week in the presence of rbIL-2 were incu-
bated for 24 h in triplicates of 105, in the presence or
absence of 0.5 U/ml rbIL-12. To assess the ability of mAb-
ligation of the CD2 receptor to trigger IFN-γ production,
NK cells were cultured in triplicates of 2 × 105 in 96-well
MaxiSorp plates (NUNC, Denmark) pre-coated overnight
in 0.05 M carbonate buffer (pH 9.6) with either of two
anti-CD2 mAbs (MUC2A, BAQ95A), with anti-NKp46
mAb (AKS1), anti-CD8 mAb (BAQ111A;IgM) or none. In
both types of experiment, medium was always containing
100U/ml rbIL-2. IFN-γ production in the supernatants
was assessed using an ELISA (Bovine IFN-γ EASIA, Bio-
source, Nivelles, Belgium) according to the manufac-
turer's instructions. Concentrations were calculated from
a standard curve made using purified bovine IFN-γ, kindly
provided by Dr Stephen Jones (Pfizer, Melbourne, Aus-
tralia).
NK cell cytotoxicity assays
The cytotoxic capacity of IL-2 activated bovine NK cells or
subsets was tested in a standard 51Cr release assay as pre-
viously described [12], using the bovine target cell lines
MDBK, BL3.1 or KN-31 (generic calf kidney cell line) or
murine P815. The BL3.1 line is MHC class I-impaired,
thus potentially devoid of important NK-cell inhibitory
ligands [53], while P815 expresses Fcγ-receptors, allowing
reverse antibody linking for redirected lysis. Specific 51Cr
release was calculated on the basis of the ratio [(sample
release – spontaneous release)/(total release – spontane-
ous release)] and lytic units (LU) were calculated as the
capacity to kill 20% of targets contained within 107 effec-
tors, as described by Bryant and colleagues [54]. In redi-
rected lysis assays, the effector cells were preincubated for
20–30 min with 1 µg/ml of mAbs against NKp46 (AKS1),
CD8 (CACT80C) or CD2 (BAQ95A) (all IgG1).
Expression of recombinant bovine interleukin-2
As bovine NK cells do not proliferate in response to
human IL-2 [11,12], bovine rbIL-2 was produced as fol-
lows: mRNA was isolated from conA stimulated bovine
PBMC with Dynabeads Oligo (dT)25 (Dynal) and cDNA
was synthesized by SuperScript™ II RNase H- Reverse Tran-
scriptase using oligo (dT)12–18 (both Invitrogen) The cod-
ing region of bovine IL-2 [GenBank: M12791] [55] was
amplified by PCR using PfuUltra™ High-Fidelity DNA
Polymerase (Stratagene, La Jolla, CA) and gene-specific
primers with BamHI and XhoI restriction sites: 5' GGATC-
CTCAACTCCTGCCACAATGTA 3' and 5' CTCGAGTTAA-
GACTAACAGTTACAAAAGGT 3'. The PCR product was
purified by agarose gel electrophoresis and QIAquick Gel
Extraction Kit (Qiagen, Hilden, Germany), incubated
with Taq DNA polymerase (Invitrogen), cloned into pCR®
2.1-TOPO Vector (Invitrogen), released by BamHI and
XhoI digestion and subcloned into pcDNA I (Invitrogen).
The correctness of this construct was verified by sequenc-
ing. 20 µg of plasmid DNA was mixed with 120 µl Lipo-
fectamine (Invitrogen) in 2.8 ml Opti-MEM (Invitrogen)
and incubated for 20–30 min at room temperature. 11.2
ml Opti-MEM were then added and the mixture trans-
ferred to a 160-cm2 flask containing a 70% confluent layer
of 293T cells that had been washed three times with Opti-
MEM. After 6 h, 14 ml of RPMI 1640 medium/20% FCS
(Invitrogen) was added. After another 6 h, cells were
washed twice in HBSS (Invitrogen) and RPMI/10 % FCS
was added. The medium, containing rbIL-2, was harvested
twice within three days, sterile filtered and assayed in an
IL-2 bioassay based on proliferation of 4 days ConA stim-
ulated PBMC as measured by 3H labeled thymidine incor-
poration. 1 U is defined as the amount of IL-2 inducing
half the maximal proliferation of ConA blasts. The super-
natant contained 10000 U rbIL-2/ml, was stored at -20°C,
and was used without further purification at the described
concentrations.
Detection of gene expression
The expression of several NK cell receptors was detected in
CD2+ and CD2- NK cell subsets by reverse transcriptase
PCR. mRNA was harvested by µMACS mRNA Isolation Kit
(Miltenyi Biotech) from 0.5–1 × 107cells and cDNA was
synthesized by SuperScript™ III RNase H- Reverse Tran-
scriptase using oligo (dT)12–18. The amount of cDNA tem-
plate was measured using NanoDrop spectrophotometer
(NanoDrop, Wilmington, DE, USA). Intron spanning
primers generating products of about 500 bp were
designed based on sequences previously described
[29,30]. NKp46 forward: 5' GAGCGATGCCTTC-
CACACTTGC 3' and reverse 5' GGTTGTTGTAG-
GAGCCAAAGCATCTGT 3'; annealing temperature 68°C,
CD16: forward 5' GTGGTGGCACAATGGGAC 3' and
reverse 5' GCCATCCCTCCATTCCTC 3', annealing temp.
62°C; KIR: forward 5' AATGTGACCCTCCGCTGTC 3' and
reverse 5' AACAGTGGGTCGCTGGAGT 3', annealing
temp. 64°C; CD94/KLRD1: forward 5' CCTTGTGTTGAT-
GGCTGCTT 3' and reverse 5' AAAATCCTTCCTCTT-
GGGTT 3' annealing temp. 58°C; KLRJ forward 5'
TGTGGATTCTTTGGTTACCAG 3' and reverse 5' TGAG-
GCCAGAAGGAAGAGAA 3' annealing temp. 59°C;
GAPDH forward AGTGGGGTGATGCTGGTGCT, reverse
TCCAGGCGGCAGGTCA, annealing temp. 66°C (477bp
product). 600 ng of cDNA was added to three parallel PCR
reactions run at 20, 25 or 30 cycles with DynazymeBMC Immunology 2006, 7:10 http://www.biomedcentral.com/1471-2172/7/10
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(Finnzymes, Espoo, Finland). Initial analysis revealed that
NKp46 was equally expressed in both NK cell subsets in
comparision to GAPDH (not shown), and its surface
expression was also at equal levels. Intensity of PCR prod-
ucts was determined using NKp46 as a reference gene,
using KODAK 1D Image Analysis software (Eastman
Kodak, New Haven, CT, USA).
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